Story perspectives

Trump Unveils Medicare Drug Prices Amid Controversy

11/30/2025

Summary

Story summary

U.S. President Donald Trump announced Medicare drug prices for 15 medications, effective 2027, with savings of $12 billion.
The move follows the second round of Inflation Reduction Act negotiations, opposed by Republicans.
Trump officials praised the results as a success over Biden-led talks, while experts dispute the claim.
Critics say Republican amendments weakened future negotiations for expensive cancer drugs, and advocacy groups urge strengthening the IRA to broaden access.

History

Historical Context

The Inflation Reduction Act, signed into law by President Biden on August 16, 2022, empowers Medicare to negotiate drug prices, a significant shift from the 2003 Medicare Part D legislation that prohibited such negotiations. This act aims to lower prescription drug costs, potentially saving taxpayers $98.5 billion over the next decade, and reflects ongoing debates about healthcare reform in the U.S.

1 of 2

Story summary

U.S. President Donald Trump announced Medicare drug prices for 15 medications, effective 2027, with savings of $12 billion.
The move follows the second round of Inflation Reduction Act negotiations, opposed by Republicans.
Trump officials praised the results as a success over Biden-led talks, while experts dispute the claim.
Critics say Republican amendments weakened future negotiations for expensive cancer drugs, and advocacy groups urge strengthening the IRA to broaden access.

1 / 2